Back
Immunovant, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
IMVT
Immunovant, Inc.
Last Price:
$25.63
Seasonality Move:
-11.86%
7 Day Trial
ALL ACCESS PASS
$
7
Immunovant, Inc. Stock Forecast
-
Over the next 52 weeks, Immunovant, Inc. has on average historically risen by 42.1% based on the past 6 years of stock performance.
-
Immunovant, Inc. has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Immunovant, Inc. Stock Undervalued?The current Immunovant, Inc. [IMVT] share price is $25.94. The Score for IMVT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
IMVT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Immunovant, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Immunovant, Inc. has on average historically risen by 42.1% based on the past 6 years of stock performance.
Immunovant, Inc. Stock Rating
Sell
39
Immunovant, Inc. (IMVT)
is a Sell
Is Immunovant, Inc. overpriced?
-
Immunovant, Inc. has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Immunovant, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunovant.com
52-Week Data
52-Week High:
27.92
52-Week Low:
12.72
Prediction Charts
Market Cap:
5.3B
Price in USD:
25.94
Volume:
1.4M
Beta:
0.76
Technical Analysis
SMA50:
25.64
SMA100:
22.84
SMA200:
19.32
52-Wk Change:
34.13%
Stock Predictions
-
Is Immunovant, Inc. stock public?Yes, Immunovant, Inc. is a publicly traded company.
-
What is the Immunovant, Inc. stock quote today?The Immunovant, Inc. stock price is 25.94 USD today.
-
How to buy Immunovant, Inc. stock online?You can buy Immunovant, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-23 | 26.06 | 26.01 | 26.60 | 25.30 |
| Jan-26 | 25.82 | 26.60 | 27.44 | 25.55 |
| Jan-27 | 26.62 | 26.83 | 27.11 | 26.32 |
| Jan-28 | 26.80 | 26.06 | 26.86 | 25.97 |
| Jan-29 | 25.92 | 26.45 | 26.52 | 25.76 |
| Jan-30 | 26.20 | 26.00 | 26.42 | 25.42 |
| Feb-2 | 25.90 | 26.08 | 26.43 | 25.79 |
| Feb-3 | 26.07 | 25.80 | 26.82 | 25.51 |
| Feb-4 | 25.79 | 25.15 | 25.96 | 24.38 |
| Feb-5 | 24.84 | 24.06 | 25.93 | 23.90 |
| Feb-6 | 26.88 | 27.05 | 27.35 | 24.85 |
| Feb-9 | 27.69 | 27.49 | 27.92 | 26.25 |
| Feb-10 | 27.50 | 26.68 | 27.58 | 26.46 |
| Feb-11 | 26.78 | 25.94 | 26.95 | 25.62 |
Immunovant, Inc. Earnings
Immunovant, Inc. Earnings Report: Per Share Immunovant, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Immunovant, Inc. Forecast Revenue Growth
Immunovant, Inc. Stock Analysis: Historical quarterly revenues per share for Immunovant, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.19 per share, an increase this year of $0.28 per share, and a decrease next year of $0.08 per share.
* Immunovant, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.